Subscribe To
Immunotherapeutic benefits of the dpx delivery platform featured in two poster presentations at the aacr-nci-eortc conference on molecular targets and cancer therapeutics
DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $IMV #DeliveryPlatform--IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage bio...
October 7, 2021, 9:05 am
Oric pharmaceuticals presents initial clinical data from phase 1b trial of oric-101 in combination with enzalutamide and preclinical data on oric-114 at aacr-nci-eortc
ORIC-101 and enzalutamide combination regimen at the recommended Phase 2 dose was well tolerated; adverse events generally consistent with single agen...
October 7, 2021, 8:55 am
Oric pharmaceuticals presents initial clinical data from phase 1b trial of oric-101 in combination with enzalutamide and preclinical data on oric-114 at aacr-nci-eortc
ORIC-101 and enzalutamide combination regimen at the recommended Phase 2 dose was well tolerated; adverse events generally consistent with single agen...
October 7, 2021, 8:55 am
Oric pharmaceuticals presents initial clinical data from phase 1b trial of oric-101 in combination with enzalutamide and preclinical data on oric-114 at aacr-nci-eortc
ORIC-101 and enzalutamide combination regimen at the recommended Phase 2 dose was well tolerated; adverse events generally consistent with single agen...
October 7, 2021, 8:55 am
Talem therapeutics announces multi-target antibody discovery research collaboration with pierre fabre
VICTORIA, British Columbia & CASTRES, France--(BUSINESS WIRE)---- $IPA #Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (...
October 7, 2021, 8:38 am
Talem therapeutics announces multi-target antibody discovery research collaboration with pierre fabre
VICTORIA, British Columbia & CASTRES, France--(BUSINESS WIRE)---- $IPA #Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (...
October 7, 2021, 8:38 am
Talem therapeutics announces multi-target antibody discovery research collaboration with pierre fabre
VICTORIA, British Columbia & CASTRES, France--(BUSINESS WIRE)---- $IPA #Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (...
October 7, 2021, 8:38 am
Silo pharma achieves milestone - partner zylo therapeutics receive dea approval to advance silos time released ketamine technology
Englewood Cliffs NJ, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO) a development-stage bio...
October 7, 2021, 8:11 am
Silo pharma achieves milestone - partner zylo therapeutics receive dea approval to advance silos time released ketamine technology
Englewood Cliffs NJ, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO) a development-stage bio...
October 7, 2021, 8:11 am
Silo pharma achieves milestone - partner zylo therapeutics receive dea approval to advance silos time released ketamine technology
Englewood Cliffs NJ, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO) a development-stage bio...
October 7, 2021, 8:11 am
Osmt stock: why it substantially fell today
The stock price of Osmotica pharmaceuticals (NASDAQ: OSMT) fell by over 40% pre-market today. This is w...
October 7, 2021, 8:05 am
Osmt stock: why it substantially fell today
The stock price of Osmotica pharmaceuticals (NASDAQ: OSMT) fell by over 40% pre-market today. This is w...
October 7, 2021, 8:05 am
Osmt stock: why it substantially fell today
The stock price of Osmotica pharmaceuticals (NASDAQ: OSMT) fell by over 40% pre-market today. This is w...
October 7, 2021, 8:05 am
Eledon pharmaceuticals announces presentation on at-1501 at the virtual 2021 northeast amyotrophic lateral sclerosis consortium
IRVINE, Calif., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Eledon pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ...
October 7, 2021, 7:51 am
Eledon pharmaceuticals announces presentation on at-1501 at the virtual 2021 northeast amyotrophic lateral sclerosis consortium
IRVINE, Calif., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Eledon pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ...
October 7, 2021, 7:51 am
Eledon pharmaceuticals announces presentation on at-1501 at the virtual 2021 northeast amyotrophic lateral sclerosis consortium
IRVINE, Calif., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Eledon pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ...
October 7, 2021, 7:51 am
Forma therapeutics' ft-7051 is well-tolerated and demonstrates evidence of activity in initial results from ongoing phase 1 courage study in men with metastatic castration-resistant prostate cancer
WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharm...
October 7, 2021, 7:05 am
Forma therapeutics' ft-7051 is well-tolerated and demonstrates evidence of activity in initial results from ongoing phase 1 courage study in men with metastatic castration-resistant prostate cancer
WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharm...
October 7, 2021, 7:05 am
Forma therapeutics' ft-7051 is well-tolerated and demonstrates evidence of activity in initial results from ongoing phase 1 courage study in men with metastatic castration-resistant prostate cancer
WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharm...
October 7, 2021, 7:05 am
Osmotica pharmaceuticals announces pricing of $35 million underwritten public offering
BRIDGEWATER, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Osmotica pharmaceuticals plc (Nasdaq: OSMT) (“Os...
October 7, 2021, 12:31 am